Integra LifeSciences Anticipates Market Recovery in 4Q20

Integra LifeSciences reported 1Q20 orthopedic revenue of USD $21.5 million, -5.3% vs. 1Q19. Revenue tracked above company plans through January and February until COVID disruptions brought significant declines in March. For Integra as a whole, run rates declined nearly -30% in the last two weeks of March. Orthopedics declined more than -80%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us